 Home > Active Ingredient News > Study of Nervous System > How is Alzheimer's disease treated? Phase III trials of the AXS-05 are to be carried out

How is Alzheimer's disease treated? Phase III trials of the AXS-05 are to be carried out

 Last Update: 2021-01-16
 Source: Internet
 Author: User

Tags

cpt2 disease symptoms

efficacy test

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Biopharmaceutical company Axesome Therapeutics has announced the start of a study on ACCORD, which evaluates the clinical efficacy of Alzheimer's disease, as a randomized, double-blind, placebo-controlled Phase III trial to assess the efficacy and safety of AXS-05 in treating Alzheimer's disease (AD) restlessness.
AXS-05 is a new, oral, research-based NMDA subjectant.
currently has no approved AD restlessness therapy.
results of the ACCORD test are expected to be released in the second half of 2022.
Alzheimer's disease is an aggressive neurodegenerative disease that is a common form of Alzheimer's disease characterized by cognitive decline and behavioral and psychological abnormalities, including restlessness.
addition to cognitive decline, up to 70 percent of Alzheimer's patients develop restlessness, characterized by depression, aggressive behavior, destructive irritability, and inhibition.
, the symptoms can accelerate cognitive decline and increase mortality.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin White powder CAS 148553-50-8 In Stock

CAS No.: 148553-50-8

Pharmacy Grade

$0.9/KG FOB

Pregabalin High pure 99% up Pregabalin powder CAS 148553-50-8 for sale

CAS No.: 148553-50-8

Pharmacy Grade

$0.6/G FOB

Factory Price Enhancements Yohimbine Powder Yohimbine HCl CAS 65-19-0 Over 99% Purity

CAS No.: 65-19-0

Chemical Grade

$3.5-4/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.